Why ViewFlow? In 100 million surgeries a year, surgeons are flying blind regarding real-time blood flow. We’re replacing 60-year-old standards (dyes/probes) with a proprietary 20D vision algorithm. We’re not just building a camera; we’re building a clinical decision-making engine.

How do you bridge Quantum Physics, NASA, and the OR? Most medical tech fails because it’s “lab-perfect” but “clinical-incompatible.” My background—spanning NASA research in quantum molecular dynamics to large-scale commercial rollouts for Roche and Merck—gives me the unique ability to speak both languages. I know how to invent the math and how to navigate the FDA/ISO regulatory hurdles required to get it into a surgeon’s hands.

What is the “ViewFlow Moat”? It’s not just the hardware; it’s the intelligence. We built a proprietary 20-dimensional vision algorithm that solves the fundamental computational challenge of surface-to-molecule interaction. We’ve turned a complex physics problem into a simple, real-time clinical tool.

Why Duke and Rex-UNC? Clinical adoption is the ultimate “de-risking” event. We aren’t testing in a vacuum; we are validating our tech in the most demanding surgical environments in the country. This proves that ViewFlow isn’t just a prototype—it is the new clinical standard for surgical precision.